ReNetX Bio’s cover photo
ReNetX Bio

ReNetX Bio

Biotechnology

New Haven, CT 349 followers

About us

Our mission is to provide first-in-class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), glaucoma, and traumatic brain injury. Our treatment, AXER-204, hopes to rebuild connections between healthy and damaged neurons through the blocking of receptors that naturally inhibit axonal growth. We are currently approaching Phase 2 of testing.

Website
http://www.renetx.com
Industry
Biotechnology
Company size
2-10 employees
Headquarters
New Haven, CT
Type
Privately Held
Specialties
Biotechnology

Locations

Employees at ReNetX Bio

Similar pages

Browse jobs

Funding

ReNetX Bio 3 total rounds

Last Round

Series unknown

US$ 2.8M

See more info on crunchbase